Lasofoxifene, a next generation estrogen receptor modulator: preclinical studies

Clinical calcium

Volumn 14, Issue 10, 2004, Pages 85-93

  Maeda, Tomoko ^a   Ke, Hua Zhu ^a   Simmons, Hollis ^a   Thompson, David ^a  

^a PFIZER GLOBAL RESEARCH AND DEVELOPMENT   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CHOLESTEROL; CIS 1R (4' PYRROLIDINOETHOXYPHENYL) 2S PHENYL 6 HYDROXY 1,2,3,4 TETRAHYDRONAPHTHALENE, TARTRATE SALT; CIS-1R-(4'-PYRROLIDINOETHOXYPHENYL)-2S-PHENYL-6-HYDROXY-1,2,3,4-TETRAHYDRONAPHTHALENE, TARTRATE SALT; ESTROGEN RECEPTOR; PYRROLIDINE DERIVATIVE; SELECTIVE ESTROGEN RECEPTOR MODULATOR; TETRALIN DERIVATIVE;

ANIMAL; BLOOD; BONE DENSITY; BREAST TUMOR; DISEASE MODEL; DRUG ANTAGONISM; DRUG EFFECT; DRUG POTENTIATION; DRUG SCREENING; FEMALE; GENETIC TRANSCRIPTION; GENETICS; HUMAN; MOUSE; POSTMENOPAUSE OSTEOPOROSIS; RAT; REVIEW; UTERUS;

ANIMALS; BONE DENSITY; BREAST NEOPLASMS; CHOLESTEROL; DISEASE MODELS, ANIMAL; DRUG EVALUATION, PRECLINICAL; FEMALE; HUMANS; MICE; OSTEOPOROSIS, POSTMENOPAUSAL; PYRROLIDINES; RATS; RECEPTORS, ESTROGEN; SELECTIVE ESTROGEN RECEPTOR MODULATORS; TETRAHYDRONAPHTHALENES; TRANSCRIPTION, GENETIC; UTERUS;

EID: 16644397527     PISSN: 09175857     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (25)